Intravesical local anesthetics, in a wide variety of combinations, are increasingly used to treat patients with interstitial cystitis-bladder pain syndrome (IC/BPS).
Lidocaine has demonstrated properties that block the neuroinflammatory cycle associated with IC/BPS at many of the interactive points in this cycle. Intravesical lidocaine has been shown to assist in identifying the bladder as the source of pain in patients with pelvic pain. An appreciation of these anti-inflammatory effects and of the pharmacokinetics of intravesical lidocaine in patients with IC/BPS could lead to a safe and effective diagnosis and treatment for an as yet unidentified subset of patients in the IC/BPS spectrum.
Written by:
Henry RA, Morales A, Cahill CM. Are you the author?
Department of Anesthesiology and Perioperative Medicine, Queen's University, Kingston, Ontario, Canada; Department of Urology, Queen's University, Kingston, Ontario, Canada; Department of Anesthesiology and Perioperative Care, University of California Irvine, Irvine, CA.
Reference: Urology. 2015 May;85(5):1025-1033.
doi: 10.1016/j.urology.2015.01.021
PubMed Abstract
PMID: 25917728